Stroke Victims Often Suffer From Lack of Nutrients With Undiagnosed Disorder
... from a
stroke and other neurologic diseases.
dysphagia is a neurological health
problem that makes ... is possible that many more Americans suffer from
dysphagia but
it is underreported due to many patients ... of Family Physicians, 2000).
People with
dysphagia lack the muscular coordination in the throat ...
Study examines self-expanding plastic stents in the treatment of benign esophageal conditions
... the current endoscopic standard for palliation of
dysphagia resulting from malignant esophageal stenosis. ... included chest pain, neck discomfort, and
dysphagia (in 23 procedures) and nausea
and vomiting (in ... or both. Success was defined as resolution of
dysphagia and closure of the fistula or leak as seen on ...
CAPHOSOL results in minimal oral mucositis and pain in head/neck cancer patients
...
CAPHOSOL use also appeared to limit the incidence of oral pain and
dysphagia (difficulty swallowing). Grades 2 (moderate) and 3 (severe) pain were ... and more than one-third (36 percent) did not require opioids at Week 8. No
dysphagia was reported in 18 percent of the patients; of those who did experience ...
Photos: Don't Let Them See You Sweat This Summer
... side effects.
Patients with neuromuscular disorders may be at increased risk of clinically significant systemic effects including severe
dysphagia (difficulty swallowing) and respiratory compromise from typical doses of BOTOX((R)).
Precautions
Patients or caregivers should be ...
FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia
... increase greater than 12 mEq/L/24 hours) can cause osmotic demyelination syndrome (ODS), resulting in dysarthria (difficulty speaking), mutism,
dysphagia (trouble swallowing), lethargy, affective changes (mood changes), spastic quadraparesis (involuntary muscle weakness), seizures, coma and death. In ...
Two Studies at AACE 2009 Annual Meeting Highlight Effects of Welchol(R) (colesevelam HCl) on Blood Glucose and LDL-C in Patients with Type 2 Diabetes
... when treating patients with gastroparesis, gastrointestinal motility disorders, major gastrointestinal tract surgery, and when treating patients with
dysphagia and swallowing disorders.
Welchol reduces gastrointestinal absorption of some drugs. Drugs with a known interaction with colesevelam (glyburide, ...
Data from Pooled Analyses Demonstrates Welchol, Combined with Metformin- or Sulfonylurea-Based Therapy, Significantly Lowers Blood Glucose in Adults with Type 2 Diabetes
... when treating patients with
gastroparesis, gastrointestinal motility disorders, major gastrointestinal
tract surgery, and when treating patients with
dysphagia and swallowing
disorders.
Welchol reduces gastrointestinal absorption of some drugs. Drugs with a
known interaction with colesevelam (glyburide, ...
Welchol(TM) Added to the American College of Endocrinology/American Association of Clinical Endocrinologists 'Road Maps to Achieve Glycemic Control in Patients with Type 2 Diabetes Mellitus'
... when treating patients with
gastroparesis, gastrointestinal motility disorders, major gastrointestinal
tract surgery, and when treating patients with
dysphagia and swallowing
disorders.
Welchol reduces gastrointestinal absorption of some drugs. Drugs with a
known interaction with colesevelam ...
ASGE encourages patients to see a physician if they experience symptoms suggestive of GERD
... to discern from cardiac-related pain), asthma, cough, nausea, bad breath and loss of tooth enamel.
Complications of acid reflux can include
dysphagia (difficulty swallowing), regurgitation, and an increased risk of esophageal cancer. This is due to progressive damage to the esophagus, resulting in ...
Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
... when treating patients with
gastroparesis, gastrointestinal motility disorders, major gastrointestinal
tract surgery, and when treating patients with
dysphagia and swallowing
disorders.
Welchol reduces gastrointestinal absorption of some drugs. Drugs with a
known interaction with colesevelam (glyburide, ...
Dysphagia in Medical Technology
CAPHOSOL(R) Relieves Oral Mucositis (OM) and Improves Quality-of-Life in Cancer Patients Receiving Chemoradiation
... Sixty-five percent of patients ranked
their
dysphagia symptoms (difficulty swallowing) as Grade 0, ... undergoing RT +/-
chemo treatment reported a
dysphagia Grade of 0.
These data confirm that early ... reduces the
occurrence and severity of OM,
dysphagia and oral pain in patients
undergoing ...
Merz Pharmaceuticals Announce Three Studies of NT-201 - (Botulinum neurotoxin type A Free From Complexing Proteins)
... U group and 46.0% of the 240 U group. AEs reported most frequently were
dysphagia (4.3% vs 8.5% vs 16.0%), neck pain (4.3% vs 8.5%, vs 10.0%), and injection ... U group and in 71.0% of the 240 U group. AEs reported most frequently were
dysphagia (0% vs 19.4% vs 22.6%), muscular weakness (3.6% vs 6.5% vs 22.6%), and ...
Merz Pharmaceuticals Announces Results of Three Clinical Trials With NT-201 (Botulinum Neurotoxin Type A Free From Complexing Proteins) in Movement Disorder Patients
... in 41.9% of the placebo group, 56.4% of the 120 U group and 55.6% of the 240 U group. AEs reported most frequently for each group respectively were
dysphagia (2.7% vs 12.8% vs 18.5%), neck pain (4.1% vs 6.4%, vs 14.8%), and muscular weakness (1.4% vs 6.4% vs 11.1%).
Efficacy and safety of NT-201 ...
Meritage Pharma Initiates Phase 2b Clinical Trial of Oral Viscous Budesonide for Pediatric Patients With Eosinophilic Esophagitis
... environmental allergens. People with EoE commonly have other allergic conditions such as asthma or eczema.
Symptoms of EoE may include nausea,
dysphagia (problems swallowing), vomiting, stomach pain, chest pain, heartburn, loss of weight, and food impaction. Other symptoms may include reflux that does ...
FDA Files Application To Convert ONTAK(R) (Denileukin Diftitox) to Full Approval for Use in Cutaneous T-Cell Lymphoma (CTCL)
... 98 patients: hypotension (50%), back
pain (30%), dyspnea (28%), vasodilation (28%), rash (25%), chest pain or
tightness (24%), tachycardia (12%),
dysphagia or laryngismus (5%), syncope
(3%), allergic reaction (1%), or anaphylaxis (1%). These events were severe
in 2% of patients.
-- Death during ...
New Discovery of Key Difference in Bile Acid Metabolism in Patients with Type 2 Diabetes May Suggest Underlying Disorder
... when treating patients with
gastroparesis, gastrointestinal motility disorders, major gastrointestinal
tract surgery, and when treating patients with
dysphagia and swallowing
disorders.
Welchol reduces gastrointestinal absorption of some drugs. Drugs with a
known interaction with colesevelam ...
Welchol(TM) Lowered A1C by a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated
... when treating patients with
gastroparesis, gastrointestinal motility disorders, major gastrointestinal
tract surgery, and when treating patients with
dysphagia and swallowing
disorders.
Welchol reduces gastrointestinal absorption of some drugs. Drugs with a
known interaction with colesevelam (glyburide, ...
Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
... was well tolerated at all doses,
and the majority of AEs were considered mild. The most commonly reported
adverse events were coughing (n=2) and
dysphagia (n=1). One serious AE
(hospitalization due to severe diarrhea) occurred after the last dose of
800 mcg and was judged by the investigator as ...
Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
... when treating patients with
gastroparesis, gastrointestinal motility disorders, major gastrointestinal
tract surgery, and when treating patients with
dysphagia and swallowing
disorders.
Welchol reduces gastrointestinal absorption of some drugs. Drugs with a
known interaction with colesevelam ...
ERBITUX(R) Meets Primary Endpoint of Increasing Survival in Phase III Lung Cancer Study
... (n=212) were mucositis-stomatitis (93%/94%),
acneform rash (87%/10%), radiation dermatitis (86%/90%), weight loss
(84%/72%), xerostomia (72%/71%),
dysphagia (65%/63%), asthenia (56%/49%),
nausea (49%/37%), constipation (35%/30%) and vomiting (29%/23%). The most
common adverse events seen in patients with ...
Dysphagia in Medical Definition
Thickened fluids
... Thickened fluids are often used for people with
dysphagia , a disorder of swallowing function. The thicker consistency makes it less likely that an individual with
dysphagia will aspirate while they are drinking.
There are several levels of ...
Dysphagia in Medical Dictionary
Dysphagia
...
dysphagia is a term that means "difficulty swallowing." It ... during the process of swallowing. What causes
dysphagia ?
dysphagia occurs when there's a problem with any part of ...
Endoscopic
... lighted tube. Endoscopic -placed stent s to provide palliation of
dysphagia .[2] Radiation therapy with or without intra luminal intubation and dilation . Intra luminal brachytherapy to provide palliation of
dysphagia .[3,4] ... Endoscopic retrograde cholangiopancreatography, an ...
Acid Reflux
... reflux also occurs, causing the gullet to become inflamed, which also makes swallowing very painful. When symptoms of GERD are also present with
dysphagia , treating this condition may produce improvements in your child's ability to swallow. As the esophagus and throat are less irritated by acid ...
Breathing
... , and symptoms of hypoxia " or lack of oxygen . Drug resistance The result of cells' ability to resist the effects of a specific drug .
dysphagia Difficulty in swallowing. Dyspnea Difficult or painful breathing ; shortness of breath. Dysuria Difficult or painful urination . E ... As the ...
Drug
... that usually kill them. See Cross- Resistance . Drug resistance The result of cells' ability to resist the effects of a specific drug .
dysphagia Difficulty in swallowing. Dyspnea Difficult or painful breathing ; shortness of breath. Dysuria Difficult or painful urination . E ... Drug ...
Drug Resistance
... drugs that usually kill them. See Cross- Resistance . Drug resistance The result of cells' ability to resist the effects of a specific drug .
dysphagia Difficulty in swallowing. Dyspnea Difficult or painful breathing ; shortness of breath. Dysuria Difficult or painful urination . E ... Why ...
Dyspnea
... , dyspnea (difficulty breathing ), or pallor . Drug resistance The result of cells' ability to resist the effects of a specific drug .
dysphagia Difficulty in swallowing. Dyspnea Difficult or painful breathing ; shortness of breath. Dysuria Difficult or painful urination . E ... ...
Emesis
... cause of vomiting blood ( hemat emesis ). Determine the cause of persi stent upper abdominal pain or bloating , difficulty in swallowing (
dysphagia ), vomiting , or unexplained weight loss . Kytril (granisetron hydro chloride ) tablets Kytril (granisetron hydro chloride ) oral solution ...
Esophageal stricture
... to be dilated, or widened, under anesthesia . This procedure may have to be repeated periodically. What is the long-term outlook for a child with
dysphagia ? Recurrence of bleeding after treatment Hypovolemic shock Esophageal stricture after surgery or endoscopic therapy Worsening ...
Flatulence
... esophagus . Headache and pain in muscle s and joints . Constipation , diarrhea , and increased gas ( flatulence ). Difficulty swallowing (
dysphagia ). Allergic reactions . Giardiasis ( Giardia lamblia) Intestinal Complications of Inflammatory Bowel Disease Intestinal Gas ( Belching ...
More>>
Dysphagia in Biological News
Dysphagia in Biological Technology